Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

NCT03110822

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Global Oncology, Inc. Alhambra, California, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States

Compassionate Care Research Group, Inc. Fountain Valley, California, United States

View all 13 locations

View Trial Details

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NCT05573802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece

Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece

View Trial Details

Recruiting

FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)

NCT04349358

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CHU de Besançon Besançon, France

Centre Georges François Leclerc Dijon, France

CHU de Dijon Dijon, France

View Trial Details

Recruiting

A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

NCT06084962

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma

NCT04558931

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Karolinska University Hospital, Huddinge Stockholm, Sweden

View Trial Details

Recruiting

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

NCT00230685

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Respiratory Medicine, Hammersmith Hospital London, United Kingdom

View Trial Details

Recruiting

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

NCT00230620

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Imperial College Hammersmith Campus London, United Kingdom

View Trial Details

Recruiting

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

NCT06045091

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

NCT05338190

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Recruiting

IgIV Plus Prednisone vs High-dose Dexamethasone for ITP

NCT04968899

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions